Role of Plasminogen Activator Inhibitor Type 1 in Pathologies of Female Reproductive Diseases.

about

Prostaglandin E2 receptor 3 (EP3) signaling is induced in placentas with unexplained recurrent pregnancy losses (uRPL).

P2860

Q52560328-5BE2FEB7-FD7B-4E69-8131-37676A7F996E

P2860

Role of Plasminogen Activator Inhibitor Type 1 in Pathologies of Female Reproductive Diseases.

Item

http://www.wikidata.org/entity/Q38649391

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Role of Plasminogen Activator ...... Female Reproductive Diseases.

@en

type

Item

label

Role of Plasminogen Activator ...... Female Reproductive Diseases.

@en

prefLabel

Role of Plasminogen Activator ...... Female Reproductive Diseases.

@en

P1476

Role of Plasminogen Activator ...... Female Reproductive Diseases.

@en

P2093

Aurelia Vattai

http://www.w3.org/2001/XMLSchema#string

Christian J Thaler

http://www.w3.org/2001/XMLSchema#string

Junyan Zhu

http://www.w3.org/2001/XMLSchema#string

Sven Mahner

http://www.w3.org/2001/XMLSchema#string

Udo Jeschke

http://www.w3.org/2001/XMLSchema#string

Viktoria von Schönfeldt

http://www.w3.org/2001/XMLSchema#string

Xi Zhang

http://www.w3.org/2001/XMLSchema#string

Yao Ye

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution

P2860

Human plasminogen activator inhibitor-1 (PAI-1) deficiency: characterization of a large kindred with a null mutation in the PAI-1 gene

Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity

Endometriosis: where are we and where are we going?

Association of plasminogen activator inhibitor-type 1 (-675 4G/5G) polymorphism with pre-eclampsia: systematic review

Prevention of type 2 diabetes mellitus in women with previous gestational diabetes mellitus

Transient reduction of placental angiogenesis in PAI-1-deficient mice

Hemostasis during normal pregnancy and puerperium.

Uteroplacental hemostasis in intrauterine fetal growth retardation.

Haemostatic changes in pregnancy.

The plasminogen activation system in tumor growth, invasion, and metastasis.

P31

scholarly article

review article

P356

10.3390/IJMS18081651

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2017-07-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28758928

http://www.w3.org/2001/XMLSchema#string

P921

female infertility of uterine origin

complications of pregnancy

genetic polymorphism

Serpin family E member 1

polycystic ovary syndrome

P932

5578041

http://www.w3.org/2001/XMLSchema#string

Role of Plasminogen Activator Inhibitor Type 1 in Pathologies of Female Reproductive Diseases.

about

P2860

P2860

Role of Plasminogen Activator Inhibitor Type 1 in Pathologies of Female Reproductive Diseases.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P31

P356

P407

P433

P478

P5008

P577

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P31

P356

P407

P433

P478

P5008

P577

P698

P921

P932